Bioxytran (OTCMKTS:BIXT) Posts Earnings Results

Bioxytran (OTCMKTS:BIXT) posted its earnings results on Friday. The company reported ($0.02) earnings per share for the quarter, Zacks reports.

Bioxytran Price Performance

Shares of Bioxytran stock traded down $0.00 during trading hours on Friday, reaching $0.03. The company’s stock had a trading volume of 4,000 shares, compared to its average volume of 83,667. The firm has a 50 day moving average price of $0.04 and a 200-day moving average price of $0.05. Bioxytran has a one year low of $0.03 and a one year high of $0.17. The stock has a market cap of $3.74 million, a P/E ratio of -1.65 and a beta of 1.95.

Bioxytran Company Profile

Bioxytran, Inc is a clinical-stage biotechnology company focused on the development of synthetic oxygen carriers and novel oxygen therapeutics for acute care and chronic disease applications. The company’s proprietary platform is designed to safely deliver therapeutic levels of oxygen to hypoxic tissues, addressing conditions such as ischemia-reperfusion injury, organ transplantation, and traumatic injury. Its lead product candidates target unmet medical needs in cardiovascular and neurological disorders, wound healing, and critical care settings.

Bioxytran’s research pipeline comprises multiple preclinical-stage assets that leverage stabilized perfluorocarbon emulsions to achieve controlled oxygen release.